Skip to content
Board of Directors
Scientific Advisory Board
Conferences and Exhibitions
CellJet 3D Bioprinter
Cell Line Development
Single Cell Dispensing
Cell Engineering and Synthetic Biology
Where to Buy
Service & Support
Sphere Fluidics’ Blogs
Optimizing the genome editing workflow with microfluidics
Learn how microfluidic technology can overcome current challenges in the genome editing workflow from Professor Steven Pollard
Exclusive insights into our latest microdroplet generator
Introducing PiSCES - an optical feedback controlled single cell encapsulation system improving high-throughput monoclonality
Creating disruptive microfluidic technologies
Dr Elvira discusses disruptive technologies, ranging from 3D-printed assembled capillary devices to blood-brain barrier-on-a-chip models.
Accelerating Synthetic Biology Using Picodroplets
Dr. Xin Li explores how picodroplet technology can overcome the current synthetic biology workflow challenges.
A Decade of Progress for Sphere Fluidics
2020 marked the tenth anniversary of Sphere Fluidics. Read about some key achievements on our journey to date
Accelerating Therapeutic Discovery and Regenerative Medicine
Professor Matthew Dalby explores accelerating and improving therapeutic discovery and regenerative medicine by inspiring the next generation of talent.
10 years since the launch of Sphere Fluidics
Professor Chris Abell talks about developing Cyto-Mine®, and novel applications of droplet-based microfluidic technology
Use of picodroplets improves early cancer cell detection
Professor Wilhelm Huck discusses the application of single cell analysis in diagnostics and using droplet microfluidics to isolate circulating tumor cells.
Transforming Cell Line Development Processes
Dr Fay Saunders shares her experience of using Cyto-Mine® in CLD and recombinant protein expression at FUJIFILM Diosynth Biotechnologies.
4 Best practices for optimizing Cell Line Development processes
Dr Jon Dempsey, Pathway Biopharma, explores how companies can improve product quality and yields, as well as shorten overall cell line development timelines.
The Sphere Fluidics' SAB: Insights from Dr Tristan Vaughan
Dr Tristan Vaughan shares his perspectives on biological medicines development and the tremendous future potential of single cell analysis platforms.
How can we speed up vaccine development for COVID-19?
Our CEO, Dr Frank Craig, discusses how Cyto-Mine® reduces the cell line development process by 3 months, enabling researchers to make a new vaccine much faster
Sorting and optimizing PMT settings using Cyto-Mine®
This article outlines some techniques and tips on optimizing PMT settings for sorting and dispensing using Cyto-Mine®.
Why Make the Switch to Picodroplet-based Technologies for Antibody Discovery?
Learn more about the benefits of switching to picodroplet-based technologies for antibody discovery.
Targeting Antigen Specificity: A Revolutionary Platform for Isolating Rare Cells
Learn how the use of picodroplets increases the speed and efficiency of selective cell screening and reduces screening costs.